Showing results (551-560 of 3,371) with videos related to
Sort By:
Pageof 338
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 27, 2002
Comparative antimicrobial spectrum and activity of the desfluoroquinolone BMS284756 (T-3811) tested against non-fermentative Gram-negative bacilliW Howard, D J Biedenbach, R N JonesDiagnostic Microbiology and Infectious Disease|March 15, 2001
Activity and spectrum of BMS 284756, a new des-F (6) quinolone, tested against strains of ciprofloxacin-resistant Gram-positive cocciR N Jones, M A Pfaller, M Stilwell, et al.Antimicrobial Agents and Chemotherapy|April 1, 1980
In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strainsC N Baker, C Thornsberry, R N JonesDiagnostic Microbiology and Infectious Disease|June 1, 1997
In vitro antimicrobial activity of RU-59863, a C-7 catechol substituted cephalosporinM E Erwin, D Varnam, R N JonesInternational Journal of Antimicrobial Agents|November 17, 2001
Antimicrobial activity of BMS 284756 (T-3811) against Neisseria gonorrhoeae tested by three methodsL Deshpande, D J Biedenbach, R N JonesDiagnostic Microbiology and Infectious Disease|August 1, 1996
Clindamycin resistance among erythromycin-resistant Streptococcus pneumoniaeR N Jones, M G Cormican, A WangerDiagnostic Microbiology and Infectious Disease|April 1, 1997
Antimicrobial characteristics of quinupristin/dalfopristin (Synercid at 30:70 ratio) compared to alternative ratios for in vitro testingC Jamjian, M S Barrett, R N JonesDiagnostic Microbiology and Infectious Disease|August 1, 1995
Evaluation of Vitek and API 20S for species identification of enterococciH S Sader, D Biedenbach, R N JonesDiagnostic Microbiology and Infectious Disease|January 1, 1992
New insights into the activity of third-generation cephalosporins against pneumonia-causing bacteriaR N Jones, M E Erwin, M BaleDiagnostic Microbiology and Infectious Disease|February 1, 1996
Quality control guidelines for amoxicillin, amoxicillin-clavulanate, azithromycin, piperacillin-tazobactam, roxithromycin, ticarcillin, ticarcillin-clavulanate, trovafloxacin (CP 99,219), U-100592, and U-100766 for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Results from multicenter trialsS Worth, M E Erwin, R N JonesPageof 338